A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

Cholera remains a major cause of infectious diarrhea globally. Despite the increased availability of cholera vaccines, there is still an urgent need for other effective interventions to reduce morbidity and mortality. Furthermore, increased prevalence of antibiotic-resistant Vibrio cholerae threaten...

Full description

Bibliographic Details
Main Authors: Rahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim, Katarzyna Fraczek, Steven D Dong, Christopher Gast, Laina D Mercer, Michael Raine, Sharon M Tennant, Wilbur H Chen, Eugenio L de Hostos, Robert K M Choy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-11-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0009969

Internet

https://doi.org/10.1371/journal.pntd.0009969

Similar Items